Translational IHC Consultant

Job Summary

Working remotely as part of the Early Drug Development team, the Translational IHC Consultant will bridge pathology, biomarker, and clinical development by ensuring high-quality tissue biomarker data generation to inform baseline, compound MoA, target engagement, and safety.

Key Responsibilities

• Collaborate with selected CRO to develop, optimize, and validate chromogenic IHC, mIF, and spatial Omics assays, ensuring they are phase-appropriate and fit-for-purpose
• Partner with TR scientists, clinical development, and pathologists to translate biological questions into quantitative image-based endpoints and computational workflows
• Interpret data in collaboration with Translational scientists and pathologists, correlating findings with clinical endpoints and peripheral biomarkers

Required Qualifications

• Ph.D. in Pathology, Immunology, Oncology, or a related field
• 5+ years of experience in Translational biomarker development and IHC/mIF assay development in oncology and immunology
• Deep understanding of tumor microenvironment (TME) and immune cell phenotyping
• Experience supporting clinical trials
• Proficiency in image analysis platforms such as HALO, VisioPharm, or QuPath